NCT07520864

Brief Summary

Weightlifting is a high-intensity strength-power sport where performance depends on maximal force, power output, and technical execution in the snatch and clean and jerk. Due to the sport's short-duration efforts, the ATP-PCr system predominates, with glycolysis supporting recovery between attempts. Given these demands, ergogenic aids are commonly used. While some supplements show limited or inconsistent evidence, caffeine stands out as one of the most well-supported for enhancing strength and power, mainly through central nervous system stimulation. Although its benefits are well documented in other strength sports, research specifically in Olympic weightlifting is scarce. Therefore, this study aimed to examine the effects of caffeine on neuromuscular and competition performance in elite weightlifters, hypothesizing a positive effect.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2026

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2026

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2026

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

April 2, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 9, 2026

Completed
Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

14 days

First QC Date

April 2, 2026

Last Update Submit

April 2, 2026

Conditions

Keywords

dietary supplementsergogenic aidsstrengthcaffeine

Outcome Measures

Primary Outcomes (1)

  • Weightlifting competition

    The simulated competition was conducted under official weightlifting conditions, following the standard order of lifts (snatch followed by clean and jerk) and using certified competition equipment. Athletes were allowed three attempts per lift, with up to 5 minutes of rest between attempts and a 10-minute rest period between lifts. Two experienced Level II coaches independently judged each lift, and only those approved by both were considered valid. From this protocol, key variables were derived, including competition strategy (load selected per attempt), competition results (best valid snatch, clean and jerk, and Olympic total), and the number of valid attempts performed in each exercise.

    Four weeks

Secondary Outcomes (6)

  • Countermovement jump

    2 weeks

  • Deep squat jump

    2 weeks

  • isometric start position pull

    2 weeks

  • Isometric handgrip strength

    2 weeks

  • Rating of perceived exertion (RPE)

    2 weeks

  • +1 more secondary outcomes

Study Arms (2)

Caffeine supplementation

EXPERIMENTAL

Participants ingested an opaque capsule containing 3 mg·kg-¹ of anhydrous caffeine (HSN, Granada, Spain). The capsule was consumed with 200 mL of water under direct supervision of the researchers to ensure compliance with the ingestion protocol.

Dietary Supplement: Placebo

Placebo comparator

PLACEBO COMPARATOR

Participants ingested an opaque capsule containing an inert substance (cellulose; Guinama, Valencia, Spain). The capsule was consumed with 200 mL of water under direct supervision of the researchers to ensure compliance with the ingestion protocol.

Dietary Supplement: Caffeine

Interventions

PlaceboDIETARY_SUPPLEMENT

Participants ingested an identical opaque capsule containing an inert substance (cellulose; Guinama, Valencia, Spain). The capsule was also consumed with 200 mL of water under researcher supervision. This condition served as a control to compare against the caffeine condition while maintaining blinding.

Caffeine supplementation
CaffeineDIETARY_SUPPLEMENT

Participants ingested an opaque capsule containing 3 mg·kg-¹ of anhydrous caffeine (HSN, Granada, Spain). The capsule was consumed with 200 mL of water under researcher supervision to ensure compliance. This condition was designed to evaluate the ergogenic effects of caffeine on neuromuscular and weightlifting performance.

Placebo comparator

Eligibility Criteria

Age16 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Possession of a valid weightlifting federation license
  • At least two years of weightlifting experience
  • Free from injury or illness at the time of testing

You may not qualify if:

  • Caffeine intolerance
  • Presence of any chronic disease or injury within the month preceding the study
  • Habitual caffeine consumption exceeding 100 mg/day
  • Use of medications or dietary supplements during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Francisco de Vitoria

Madrid, Madrid, 28660, Spain

Location

Related Publications (1)

  • Grgic J, Trexler ET, Lazinica B, Pedisic Z. Effects of caffeine intake on muscle strength and power: a systematic review and meta-analysis. J Int Soc Sports Nutr. 2018 Mar 5;15:11. doi: 10.1186/s12970-018-0216-0. eCollection 2018.

    PMID: 29527137BACKGROUND

MeSH Terms

Interventions

Caffeine

Intervention Hierarchy (Ancestors)

XanthinesAlkaloidsHeterocyclic CompoundsPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: A randomized, double-blind, placebo-controlled crossover design was employed. Each participant completed two identical evaluation sessions separated by 7 days to ensure adequate recovery and washout of substances. Both sessions were conducted at the same time of day (10:00 a.m.) at the Spanish National Team Training Facility in Madrid. Participants were instructed to replicate their dietary intake prior to each session, avoid strenuous exercise for 24 hours, maintain proper hydration (500 mL of water before arrival), and refrain from consuming supplements or stimulants (e.g., caffeine) for 48 hours before each session and until completing the side-effects questionnaire the following day. In each session, participants ingested an opaque capsule containing either 3 mg·kg-¹ of anhydrous caffeine (HSN, Granada, Spain) or a placebo (cellulose; Guinama, Valencia, Spain), administered with 200 mL of water under researcher supervision. Following ingestion, participants completed their habitua
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

April 2, 2026

First Posted

April 9, 2026

Study Start

March 1, 2026

Primary Completion

March 15, 2026

Study Completion

March 25, 2026

Last Updated

April 9, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will be made available upon reasonable request to the investigators.

Locations